Director of Financial Planning and Analysis
March 22nd, 2010
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops medicines to treat CNS disorders and pain.
Year Established: | 2006 |
Funding: | 149 |
Address: | 12671 High Bluff Dr San Diego, CA 92130 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | 858-259-1166 |
Mail: | info@zogenix.com |
Company URL: | http://www.zogenix.com |
March 22nd, 2010
March 18th, 2010
March 18th, 2010
March 15th, 2010
March 17th, 2010
March 3rd, 2010
Abingworth Management, Ltd.,Chicago Growth Partners (William Blair Capital Partners),Clarus Ventures,Domain Associates LLC,Oxford Venture Finance,Scale Venture Partners (FKA: BA Venture Partners),Thomas, McNerney & Partners LLC
Roger L. Hawley, Chief Executive Officer and Director
Roger L. Hawley is one of our co-founders and has served as our Chief Executive Officer and as a member of our board of directors since August 2006. From January 2006 to August 2006, Mr. Hawley served as a consultant to us and to our predecessor company, which was originally known as CG Pharma, Inc. From August 2003 to January 2006 he served as Executive Vice President, Commercial and Technical Operations for InterMune, Inc., a biopharmaceutical company focused on therapies in hepatology and pulmonology. From October 2002 to July 2003, Mr. Hawley was Chief Commercial Officer at Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostics company. From 2001 to 2002, Mr. Hawley served as General Manager and Vice President of Sales and Marketing at Elan Pharmaceuticals, Inc. From 1987 to 2001, Mr. Hawley held a broad range of management positions in commercial operations, alliance/partnership management, and regional sales and corporate finance at GlaxoSmithKline, or GSK. His last position at GSK was Vice President of Sales-CNS/GI Division. From 1976 to 1987, he held various financial management positions with Marathon Oil Company, including serving four years in London, England. While at Marathon, he was a certified treasury manager and a certified public accountant. Mr. Hawley is a member of the board of directors of Cypress Bioscience, Inc., a publicly-traded pharmaceutical company and Targeted Genetics Corporation, a publicly-traded clinical-stage biotechnology company. Mr. Hawley holds a B.Sc. in Accounting from Eastern Illinois University.